Clinical Trials | December 08, 2025
Pfizer’s therapy scores major win in Phase 3 trial for Hemophilia patients with inhibitors
HYMPAVZI’s safety profile was generally favorable
HYMPAVZI’s safety profile was generally favorable
While Merck can appeal, Halozyme said it expects the order to hold
76 of 180 long COVID-associated genes also linked to ME
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
The center will offer training to super-specialist doctors and healthcare professionals in various fields
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Subscribe To Our Newsletter & Stay Updated
